Who is the CEO of ACAD? | Glauxie AI

Q: Who is the CEO of ACAD?

ACADIA Pharmaceuticals Inc. (ACAD) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Catherine E. Owen Adams. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system... Employees: 654.

Q: What does ACAD company do?

Learn what ACAD does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ACAD?

Track recent insider buys and sells for ACAD with transaction details, amounts, and trends.

Q: What sector is ACAD in?

Find ACAD sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ACAD?

🦉

ACADIA Pharmaceuticals Inc. (ACAD)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCatherine E. Owen Adams

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions...

Key Executives

Name	Title
Albert S. Kildani	Senior Vice President of Investor Relations & Corporate Communications
Allyson McMillan Youngblood	Senior Vice President of Rare Disease Franchise
Catherine E. Owen Adams	Chief Executive Officer & Director
Elizabeth Thompson	Executive Vice President and Head of Research & Development
James K. Kihara	Senior Vice President of Finance
Jennifer J. Rhodes	Executive Vice President, Chief Legal Officer & Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ACAD Profile Financials

What does ACAD company do? Are insiders buying or selling ACAD? What sector is ACAD in?